Submitted by Anonymous (not verified) on 18 July 2025 - 15:00
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 3, Status: Authorised